Date: 9.12.2016
Summary: |
|
A UK-based pharmaceutical SME s looking for novel small molecules with immune-oncology activity especially in regard to difficult to treat cancers. The SME will further develop these novel compounds to improve their efficacy and safety profiles with a view to licensing the improved molecules to larger pharmaceutical companies to take onto the market. The SME seeks to partner with universities, research Institutes and SMEs in the form of a licensing agreement or technical cooperation agreement. |
|
Reference: |
TRUK20161011001 |
Country: |
United Kingdom |
Submitted: |
December 09 2016 |
Updated: |
December 09 2016 |
|
|
|
|
KEYWORDS |
|
Market: |
In vitro Testing, Trials, Molecular design, Pharmaceuticals/fine chemicals |
Technology: |
Cytology, Cancerology, Oncology, Medical Research, Pharmaceutical Products / Drugs |
NACE: |
Manufacture of pharmaceutical preparations, Research and experimental development on biotechnology, Other research and experimental development on natural sciences and engineering |
Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Biotechnology Journals - Plant, environmetal, animal biotechnology journals
Africa Biotech - Biotechnology and African Agriculture news
More than 30 new species of bacteria discovered in patient samples
Enhanced CRISPR method enables stable insertion of large genes into the DNA of higher plants